Literature DB >> 12706669

Effects of pertussis vaccination on transmission: vaccine efficacy for infectiousness.

Marie-Pierre Préziosi1, M Elizabeth Halloran.   

Abstract

We estimated the effect of pertussis vaccination on reducing transmission from vaccinated breakthrough cases from a comprehensive follow-up of a community of 30,000 residents in Niakhar, Senegal. Using a wide spectrum of case definitions, vaccine efficacy was estimated as 1 - the ratio of secondary attack rates (SAR) in all households with cases during the calendar year 1993, a pertussis epidemic year. Vaccine efficacy for infectiousness (VEi) was 85% (95% confidence interval (CI), 46-95%) for children vaccinated with three doses of a whole-cell (WC; 94%) or an acellullar (6%) pertussis vaccine, with pertussis defined as a cough >/=21 days with paroxysms confirmed by culture, serology, or contact with a culture-confirmed person. It was high for all case definitions. Partial vaccination reduced infectiousness. Pertussis vaccination is highly effective in reducing transmission from vaccinated breakthrough cases.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12706669     DOI: 10.1016/s0264-410x(03)00007-0

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  32 in total

Review 1.  The pertussis enigma: reconciling epidemiology, immunology and evolution.

Authors:  Matthieu Domenech de Cellès; Felicia M G Magpantay; Aaron A King; Pejman Rohani
Journal:  Proc Biol Sci       Date:  2016-01-13       Impact factor: 5.349

2.  Causal Vaccine Effects on Binary Postinfection Outcomes.

Authors:  Michael G Hudgens; M Elizabeth Halloran
Journal:  J Am Stat Assoc       Date:  2006-03       Impact factor: 5.033

3.  Vaccination based control of infections in SIRS models with reinfection: special reference to pertussis.

Authors:  Muntaser Safan; Mirjam Kretzschmar; Karl P Hadeler
Journal:  J Math Biol       Date:  2012-09-05       Impact factor: 2.259

4.  Components of the indirect effect in vaccine trials: identification of contagion and infectiousness effects.

Authors:  Tyler J Vanderweele; Eric J Tchetgen Tchetgen; M Elizabeth Halloran
Journal:  Epidemiology       Date:  2012-09       Impact factor: 4.822

5.  Community transmission of rotavirus infection in a vaccinated population in Blantyre, Malawi: a prospective household cohort study.

Authors:  Aisleen Bennett; Louisa Pollock; Naor Bar-Zeev; Joseph A Lewnard; Khuzwayo C Jere; Benjamin Lopman; Miren Iturriza-Gomara; Virginia E Pitzer; Nigel A Cunliffe
Journal:  Lancet Infect Dis       Date:  2020-12-24       Impact factor: 25.071

6.  Protecting the family to protect the child: vaccination strategy guided by RSV transmission dynamics.

Authors:  Barney S Graham
Journal:  J Infect Dis       Date:  2014-02-12       Impact factor: 5.226

7.  Interference and Sensitivity Analysis.

Authors:  Tyler J VanderWeele; Eric J Tchetgen Tchetgen; M Elizabeth Halloran
Journal:  Stat Sci       Date:  2014-11       Impact factor: 2.901

Review 8.  Resolving pertussis immunity and vaccine effectiveness using incidence time series.

Authors:  Jennie S Lavine; Pejman Rohani
Journal:  Expert Rev Vaccines       Date:  2012-11       Impact factor: 5.217

9.  The Minicommunity Design to Assess Indirect Effects of Vaccination.

Authors:  M Elizabeth Halloran
Journal:  Epidemiol Methods       Date:  2012-08-01

Review 10.  Estimating influenza vaccine efficacy from challenge and community-based study data.

Authors:  Nicole E Basta; M Elizabeth Halloran; Laura Matrajt; Ira M Longini
Journal:  Am J Epidemiol       Date:  2008-10-29       Impact factor: 4.897

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.